LANGUAGE:

WHO WE ARE
What We Do
Industries

We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.

Technical Writing

Training & eLearning

Financial Reports

Scientific Articles

Multicultural Marketing

Translation

Software Localization

Website & App Localization

Translation for Regulated Companies

Interpretation

Linguistic QA

Multilingual SEO & Digital Marketing

Functional QA & Testing

Compatibility Testing

Interoperability Testing

Performance Testing

Accessibility Testing

UX/CX Testing

Create, Label, & Validate NLP Training Data

Audio & Speech Recognition Voice Applications

Annotation, Labeling, & Classification

Captioning & Tagging

Semantic Search & Segmentation

Relevance, Validation, & Judgments

Ratings & Reviews

Our experts know the in-and-outs of your industry & its challenges.

OUR PLATFORMS

COVID-19 RESOURCES

Get In Touch

Our people are our pride, helping companies resonate with their customers for 20+ years.

About Us
Key Facts
Leadership
Insights
News

We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.

Content Services
Technical Writing
Training & eLearning
Financial Reports
Scientific Articles
Multicultural Marketing

Translation Services
Translation
Software Localization
Website & App Localization
Translation for Regulated Companies
Interpretation
Linguistic QA
Multilingual SEO & Digital Marketing

Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing

AI Services
Create, Label, & Validate NLP Training Data
Audio & Speech Recognition Voice Applications
Annotation, Labeling, & Classification
Captioning & Tagging
Semantic Search & Segmentation
Relevance, Validation, & Judgments
Ratings & Reviews

Our people are our pride, helping companies resonate with their customers for 20+ years.

Life Sciences
Banking & Finance
Retail
Gaming
Automotive
Consumer Packed Goods
Technology
Industrial Manufacturing
Legal Services
Travecl & Hospitality

Our Platforms

COVID-19 RESOURCES

Get In Touch

SELECT LANGUAGE:

Disruption Series

The novel coronavirus is upending elements of daily lives around the globe. For the life sciences industry, the pandemic has massively expanded demand. The timing of respite from the upheaval is uncertain, so businesses must adapt rapidly to survive.

Clinical Trial Execution in a Pandemic Age

In this webinar, Lionbridge will talk about the implications of Covid-19 on the current clinical trial landscape and offer perspectives on the value of multimedia, language and electronic data capture of clinical outcomes assessments.

WATCH NOW

The Lionbridge Life Sciences Disruption Series eBook

This ebook is a summation of our collaboration among global experts discussing the changing regulations and logistics, new situational challenges and best practices to address them, and thought leadership on the future of healthcare and pharmaceutical companies.

Download the eBook

COVID-19: Connection and Cooperation

As businesses and governments shutter their physical locations and move online, the life science industry finds itself in even higher...

The Disruption Series: Medical Manufacturing Surge

The demand for masks is just one part of the growing medical product need. With recommendations ever in flux from ...

The Disruption Series: Maintaining Study Participants from Afar

As quarantine measures descend around the world, clinical trial participants are often unable or unwilling to make site visits. What...

Post-Pandemic Virtual Clinical Trials

The virtual landscape for clinical trials is suddenly blossoming as governments and regulatory agencies race to prevent and treat the...

The Disruption Series: Telehealth Adoption During and After COVID

Remote doctor visits are keeping patients and medical professionals at a safe distance during quarantine times. Is this shift to...

The Disruption Series: Challenges in Moving Clinical Trials Off-Site

Read all about the current challenges in conducting previously on-site clinical trials during the global pandemic, and the steps being...

The Disruption Series: Decreased Hurdles to COVID Diagnostics

The Disruption Series: Find out how the current global crisis has affected FDA lab testing policies and decreased the time...

The Disruption Series: COVID-19 Causes EU MDR Delays

Read here to learn about how COVID-19 has caused a delay in the Date of Application for the European Medical...

The Disruption Series: MedDRA Now Impacted By Coronavirus

Read here to learn how the coronavirus has affected the medical dictionary for regulatory activities (MedDRA), and how Lionbridge supports...

The Disruption Series: Readability When Remote

Readability determines whether a message is conveyed to an audience that can act on the knowledge they learned. How can your company improve this measure of accessibility?

The Disruption Series: How AI Applies to Pandemic Healthcare

Read here to learn about smart tech for the "new normal"

The Disruption Series: Listening to the Patients During a Pandemic

Read here to learn about the issues of patient engagement in remote clinical trials during the coronavirus pandemic, and how social media can be used as a solution.

The Disruption Series: The Importance of Patient Education

Learn about the importance of patient training and education for improve medical regimen compliance and the value of high quality, engaging materials from pharmaceutical companies.

The Disruption Series: The Lasting Impact of COVID-19 on Pharma

Read a summary of the Regulatory, Technology & Communication Changes to Clinical Trials due to the COVID-19 crisis.

Meet our authors

Our Lionbridge Life Sciences experts are always here to share their knowledge and skill sets. The Disruption Series offers insights from leaders like Mark Aiello and Pia Windelov on how pharma companies, healthcare organizations, CROs, governments, and regulatory agencies are changing in response to COVID-19—and how you can keep up.

Pia Windelov

As the Director of Product Strategy for Lionbridge Life Sciences, Pia brings 15 years’ experience in R&D in the pharmaceutical, CRO, and MedTech sectors.

Nataliya Volohov

As the Practice Lead COA, Nataliya draws on her extensive experience within the clinical research industry to develop and support the delivery of Lionbridge Life Sciences’ product strategies.

Mark Aiello

With an extensive regulatory background, Mark partners with customers to bring life-saving products to market while meeting and exceeding regulatory standards.

Contact Us

Reach out to see how Lionbridge can help your adapt your business to COVID-19.

WHO WE ARE

WHAT WE DO

INDUSTRIES